In vitro radiation studies on Ewing's sarcoma cell lines and human bone marrow: application to the clinical use of total body irradiation (TBI)
Journal Article
·
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
Patients with Ewing's sarcoma who present with a central axis or proximal extremity primary and/or with metastatic disease have a poor prognosis despite aggressive combination chemotherapy and local irradiation. In this high risk group of patients, total body irradiation (TBI) has been proposed as a systemic adjuvant. To aid in the design of a clinical TBI protocol, the authors have studied in the in vitro radiation response of two established cell lines of Ewing's sarcoma and human bone marrow CFUc. The Ewing's lines showed a larger D/sub 0/ and anti-n compared to the bone marrow CFU. No repair of potentially lethal radiation damage (PLDR) was found after 4.5 Gy in plateau phase Ewing's sarcoma cells. A theoretical split dose survival curve for both the Ewing's sarcoma lines and human bone marrow CFUc using this TBI schedule shows a significantly lower surviving fraction (10/sup -4/-10/sup -5/) for the bone marrow CFUc. Based on these in vitro results, two 4.0 Gy fractions separated by 24 hours is proposed as the TBI regimen. Because of the potentially irreversible damage to bone marrow, autologous bone marrow transplantation following the TBI is felt to be necessary. The details of this clinical protocol in high risk Ewing's sarcoma patients are outlined.
- Research Organization:
- National Cancer Inst., Bethesda, MD
- OSTI ID:
- 6579365
- Journal Information:
- Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 10:7; ISSN IOBPD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Intensive combined modality therapy including low-dose TBI in high-risk Ewing's sarcoma patients
Incidence and management of secondary malignancies in patients with retinoblastoma and Ewing's sarcoma
Radiographic appearance of Ewing sarcoma of the hands and feet: report from the Intergroup Ewing Sarcoma Study
Journal Article
·
Wed Nov 30 23:00:00 EST 1983
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:5011978
Incidence and management of secondary malignancies in patients with retinoblastoma and Ewing's sarcoma
Journal Article
·
Wed May 01 00:00:00 EDT 1991
· Oncology (Williston Park, N.Y.); (United States)
·
OSTI ID:5011636
Radiographic appearance of Ewing sarcoma of the hands and feet: report from the Intergroup Ewing Sarcoma Study
Conference
·
Thu Jan 31 23:00:00 EST 1985
· AJR, Am. J. Roentgenol.; (United States)
·
OSTI ID:5610853
Related Subjects
550603 -- Medicine-- External Radiation in Therapy-- (1980-)
560121* -- Radiation Effects on Cells-- External Source-- (-1987)
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMAL CELLS
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BIOLOGICAL RECOVERY
BIOLOGICAL REPAIR
BONE MARROW CELLS
CELL KILLING
CFU
CONNECTIVE TISSUE CELLS
DISEASES
ELECTROMAGNETIC RADIATION
ENERGY RANGE
EXTERNAL IRRADIATION
FRACTIONATED IRRADIATION
IN VITRO
IONIZING RADIATIONS
IRRADIATION
MEV RANGE
MEV RANGE 01-10
NEOPLASMS
RADIATION EFFECTS
RADIATIONS
RADIOINDUCTION
RECOVERY
REPAIR
SARCOMAS
SOMATIC CELLS
SURVIVAL CURVES
TUMOR CELLS
WHOLE-BODY IRRADIATION
X RADIATION
560121* -- Radiation Effects on Cells-- External Source-- (-1987)
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMAL CELLS
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BIOLOGICAL RECOVERY
BIOLOGICAL REPAIR
BONE MARROW CELLS
CELL KILLING
CFU
CONNECTIVE TISSUE CELLS
DISEASES
ELECTROMAGNETIC RADIATION
ENERGY RANGE
EXTERNAL IRRADIATION
FRACTIONATED IRRADIATION
IN VITRO
IONIZING RADIATIONS
IRRADIATION
MEV RANGE
MEV RANGE 01-10
NEOPLASMS
RADIATION EFFECTS
RADIATIONS
RADIOINDUCTION
RECOVERY
REPAIR
SARCOMAS
SOMATIC CELLS
SURVIVAL CURVES
TUMOR CELLS
WHOLE-BODY IRRADIATION
X RADIATION